Washington companies win $34 million in Therapeutic Discovery Project Grants

Washington life sciences companies won more than $34 million in grants through the U.S. Internal Revenue Service under the Qualifying Therapeutic Discovery Project Program which was created by the Affordable Care Act. The grant covers up to 50 percent of the cost of qualifying biomedical research investments made in 2009 and 2010, up to a maximum of $5 million per firm, and is limited to companies with no more than 250 employees. Several clients of Washington Technology Center received grants, including EKOS, Healionics, Insilicos, IsoRay Medical, NanoString Technologies, Omeros, Pathway Medical Technologies, Stratos Genomics, and VisionGate.

See a list of grants for Washington

Advertisements
This entry was posted in EKOS, Funding, Healionics, Insilicos, IsoRay, Life_Sciences, NanoString_Technologies, Omeros, Pathway_Medical_Technologies, Stratos_Genomics, VisionGate. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s